Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma.
Sci Rep
; 12(1): 18731, 2022 Nov 04.
Article
in En
| MEDLINE
| ID: mdl-36333397
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Sci Rep
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom